Oculis to Present Recent Progress in its Portfolio at Upcoming Investor Conferences 24 November, 2020
Oculis recognized as one of the Top 100 Swiss Startups and ranked in Top 10 Biotech 10 September, 2020
Oculis establishes presence in U.S. and appoints Sylvia Cheung as Chief Financial Officer 01 September, 2020
Oculis Expands Portfolio with a Novel Phase II-stage Anti-TNF alpha Antibody Fragment 04 January, 2019
Oculis appoints Pravin U. Dugel, M.D. as Chairman of its Scientific Advisory Board 25 September, 2018
Prof. Stefansson awarded Peter Watson prize and chair of Cambridge Ophtha. symposium 27 September, 2017